Olema Oncology, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced its participation in three upcoming investor conferences: TD Cowen Oncology Innovation Summit on May 26, Jefferies Global Healthcare Conference on June 3, and Goldman Sachs Global Healthcare Conference on June 9. These events will feature fireside chats and provide updates on Olema's pipeline, including its lead drug palazestrant in Phase 3 trials and OP-3136 in Phase 1. Live webcasts will be available on Olema's investor relations website. This participation highlights Olema's ongoing efforts to engage investors and share progress on its targeted cancer treatments.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
Crypto investigator ZachXBT criticized all current hardware wallets as insecure and unreliable for signing transactions or storing significant funds. He highlighted Ledger as particularly problematic due to frequent updates that disrupt basic functio...
DMG Blockchain Solutions announced two strategic investments: one in MeetAmi Innovations, a Canadian fintech offering digital asset wealth management platforms, and another in Atomic47 Labs, an AI company focused on secure, sovereign AI infrastructur...
